D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance

Soonuk Choi1, Woo Jin Jang2, Young Bin Song1

  • 1Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Plos One
|August 12, 2016
PubMed

Insights

Elevated D-dimer levels in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) indicate larger infarct size and poorer outcomes. This suggests D-dimer may signal more extensive myocardial injury.

Area of Science:

  • Cardiology
  • Biomarkers
  • Medical Imaging

Background:

  • Elevated D-dimer levels are known prognostic indicators in ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI).
  • The relationship between admission D-dimer levels and structural markers of myocardial injury in STEMI patients undergoing primary PCI remains unclear.

Purpose of the Study:

  • To investigate the association between admission D-dimer levels and myocardial infarct size, area at risk (AAR), and myocardial salvage index (MSI) in STEMI patients treated with primary PCI.
  • To determine if D-dimer levels correlate with cardiac magnetic resonance (CMR) imaging findings.

Main Methods:

  • Cardiac magnetic resonance (CMR) imaging was performed on 208 patients post-primary PCI for STEMI.
  • Patients were categorized into high D-dimer (>0.5 μg/mL) and low D-dimer (≤0.5 μg/mL) groups based on admission levels.
  • Primary outcome was infarct size; secondary outcomes included AAR, microvascular obstruction (MVO), and MSI.

Main Results:

  • Patients with high D-dimer levels exhibited significantly larger myocardial infarct size (22.3% vs. 18.8%, p=0.02) compared to those with low D-dimer levels.
  • The high D-dimer group also showed a larger area at risk (AAR) (38.1% vs. 35.8%, p=0.04) and a smaller myocardial salvage index (MSI) (37.7 vs. 47.1, p=0.01).
  • Multivariate analysis confirmed high D-dimer levels were associated with larger infarct size (OR 2.59) and lower MSI (OR 2.62).

Conclusions:

  • In STEMI patients undergoing primary PCI, elevated admission D-dimer levels are associated with larger myocardial infarct size, greater AAR, and reduced MSI.
  • Admission D-dimer levels may serve as a valuable biomarker for advanced myocardial injury in this patient population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
378
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
427
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688